您当前的位置：
首页 >
文章列表页 >
64Cu/177Lu-DOTA-diZD, a small-molecule-based theranostic pair for triple-negative breast cancer
更新时间：2025-12-15

    • 64Cu/177Lu-DOTA-diZD, a small-molecule-based theranostic pair for triple-negative breast cancer

    • “In the field of triple negative breast cancer treatment, researchers have developed a new small molecule probe system integrating radionuclide diagnosis and treatment, which has achieved accurate diagnosis and treatment and provided a new treatment strategy for "immunogenic cold tumor" TNBC.”
    • Oncoradiology   Vol. 34, Issue 5, Pages: 461-469(2025)

    • DOI：10.19732/j.cnki.2096-6210.2025.05.004    

      CLC：

    • Received：18 September 2025，

      Published Online：06 November 2025，

      Published：28 October 2025

    移动端阅览

  • Yuqian HUANG, Wei FAN. 64Cu/177Lu-DOTA-diZD, a small-molecule-based theranostic pair for triple-negative breast cancer[J]. Oncoradiology, 2025, 34(5): 461-469. DOI： 10.19732/j.cnki.2096-6210.2025.05.004.

  •  
  •  

0

Views

62

下载量

0

CNKI被引量

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Research advances in EphA2-targeted theranostic radiopharmaceuticals
FAPI in radionuclide theranostics: toward a new emerging paradigm for tumor management
The value of  68 Ga-FAP-2286 PET/CT in predicting the survival of patients with advanced digestive system malignant tumors after treatment
The current status and prospects of theranostic in targeted radionuclide therapy
Analysis of correlation between clinicopathologic and ultrasonographic features of triple-negative breast cancer and axillary lymph node metastasis

Related Author

Shaoli SONG
Xiaoping XU
Xinyu LIU
Hui YANG
Ying DING
CHEN Yue
HUANG Zhanwen
ZHANG Jintao

Related Institution

Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Center for Biomedical Imaging, Fudan University
Shanghai Engineering Research Center of Molecular Imaging Probes
Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Fudan University
Department of Nuclear Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
0